In today's article we are going to explore in depth the topic of Karl-Ludwig Kley, a matter that has aroused great interest in society in recent times. We will learn about its origins, its impact on people's daily lives, the implications it has in various areas and the possible solutions that have been proposed to address it. Karl-Ludwig Kley is a complex issue that covers different dimensions, so it is essential to analyze it from different perspectives to understand its scope and adopt measures that contribute to its understanding and eventual solution. Throughout this article, we will delve into the key aspects of this topic that is so relevant today.
Karl-Ludwig Kley | |
---|---|
![]() | |
Born | |
Title | Chairman of Lufthansa |
Term | 2017- |
Successor | Stefan Oschmann |
Karl-Ludwig Kley (born 11 June 1951 in Munich) is a German business executive.
Kley studied law at the Ludwig Maximilian University of Munich (LMU) from 1974 to 1979. He completed his practical training as a lawyer in Hamburg and Johannesburg from 1979 to 1982. He earned a doctorate in law at LMU in 1986.
Kley worked for Bayer from 1982 to 1998, most recently as head of corporate finance and investor relations. He was chief financial officer and a member of the executive board of Lufthansa 1998–2006.
In 2006, Kley joined the Merck Group as a member of the executive board. He became chief executive officer (CEO) and chairman of the executive board of Merck KGaA in April 2007.[1][2] Under his leadership, Merck strengthened its two non-pharmaceutical divisions, which make laboratory supplies and specialty chemicals, and completed a $17 billion deal to buy US laboratory supplies company Sigma-Aldrich.[3] In his capacity at Merck, Kley was part of Chancellor Angela Merkel’s delegation on a state visit to Japan in 2015. Kley retired from The Merck Group in April 2016.[2]
In 2017, Lufthansa named Kley as new chairman of its supervisory board, replacing Wolfgang Mayrhuber, who had resigned six months before the end of his term.[4]